Blogs

Biologics and parenteral drug products require highly reliable packaging systems to maintain sterility and product stability throughout their lifecycle. Unlike traditional pharmaceutical products, biologics are highly sensitive to contamination, moisture, oxygen exposure, and temperature changes. Even a very small leak in the packaging system can affect product quality and patient safety.

As injectable therapies, vaccines, and advanced biologics continue to grow, Container Closure Integrity Testing (CCIT) has become an important part of pharmaceutical quality assurance. Manufacturers now require testing methods that are accurate, repeatable, and highly sensitive. Helium leak detection has become one of the most effective deterministic technologies for this purpose.

Why CCI Testing Is Important for Biologics?

Container Closure Integrity Testing helps ensure that sterile pharmaceutical products remain protected during storage, transportation, and distribution.

Key Benefits of CCIT

• Protects biologics from contamination and moisture.
• Maintains product sterility and stability.
• Supports regulatory compliance requirements.
• Extends product shelf life.
• Reduces risk to patient safety.

Traditional testing methods such as dye ingress and microbial testing may not always detect extremely small leaks. Modern biologic packaging systems require more sensitive and quantitative testing methods.

Helium Leak Detection

Helium Leak Detection (HLD) is a highly sensitive method used to identify microscopic leaks in pharmaceutical packaging systems. Helium is used as a tracer gas because it is small, inert, and safe for pharmaceutical applications.

Why Helium is Used ?

• Helium can pass through extremely small leak paths.
• It helps detect microleaks other methods may miss.
• Helium is non-reactive and does not affect products or packaging.
• Low atmospheric background improves testing accuracy.

The technology uses mass spectrometry to measure helium flow through a package defect. Unlike traditional leak testing methods, helium leak detection provides direct and quantitative leak rate measurement.

With sensitivity levels as low as 1×10?¹² l/s, helium leak testing can identify extremely small leaks that may impact sterility over time.

SIMS 1915+ for Pharmaceutical Leak Testing

The SIMS 1915+ is designed for deterministic helium leak testing in pharmaceutical and biologic packaging applications.

The system supports testing for:

• Vials
• Prefilled syringes
• Cartridges
• Combination products

SIMS 1915+ directly measures active leak rates and can detect sub-micron defects that conventional methods may miss. The system supports package development, validation, stability studies, and quality assurance programs.

It is also suitable for temperature-sensitive biologics and can support testing under cold and ultra-cold storage conditions.

High-Sensitivity Detection of Sub-Micron Leaks

Advanced helium leak detection systems can identify extremely small defects that are difficult to detect using visual inspection or traditional testing methods.

Even tiny leaks can allow gas, moisture, or microbial ingress over time, potentially affecting product sterility and stability. Helium leak testing helps manufacturers identify these defects early and improve package reliability.

Conclusion

As biologics and parenteral therapies become more advanced, reliable package integrity testing is increasingly important. Traditional testing methods may not provide the sensitivity needed for modern pharmaceutical packaging systems.

Helium leak detection provides a highly sensitive and quantitative approach to evaluating container closure integrity. Advanced systems such as the SIMS 1915+ help manufacturers improve package quality, support regulatory compliance, and protect patient safety.

Container Closure Integrity Testing (CCIT) is essential for ensuring the sterility, safety, and quality of pharmaceutical and medical device packaging systems. As the industry continues to move toward deterministic testing technologies, helium leak detection has become one of the most reliable methods for detecting and measuring package leaks.

Helium leak detection uses helium as a tracer gas combined with mass spectrometry technology to identify extremely small leaks in packaging systems such as vials, syringes, cartridges, blister packs, and flexible pouches. Due to its high sensitivity and quantitative capabilities, helium leak testing is widely used in pharmaceutical and biotechnology applications.

Why Validation is Important in CCIT ?

Validation is a critical part of helium leak detection because it confirms that the test method consistently produces accurate and repeatable results. In sterile pharmaceutical packaging, even very small leaks can impact product quality, sterility, and shelf life.

USP <1207> recognizes helium leak detection as a deterministic method because it provides measurable and objective leak rate data rather than subjective visual interpretation. Proper validation helps manufacturers establish reliable leak detection limits and maintain confidence in package integrity testing.

Validated helium leak testing methods are commonly used for:

• Vials and ampoules
• Prefilled syringes
• Cartridge systems
• Blister packaging
• Flexible packaging systems

Using Calibrated Leak Standards

One of the most important best practices in validation is the use of calibrated helium leak standards. These standards help ensure the accuracy and consistency of the testing system.

Calibrated standards are used for:

• Daily system verification
• Instrument qualification
• Method validation
• Performance checks
• Ongoing quality monitoring

PTI’s SIMS 1915+ helium leak detection systems include internal and external calibrated leak standards that support reliable and repeatable testing performance.

Using calibrated standards also helps maintain long-term consistency in leak rate measurements.

Establishing Leak Rate Acceptance Criteria

Helium leak detection provides quantitative leak rate measurements, allowing manufacturers to establish scientifically defined acceptance criteria for package integrity.

Leak rate limits are typically based on:

• Package design
• Product sensitivity
• Stability requirements
• Storage conditions
• Risk of microbial ingress

Helium leak detection can detect leaks as small as one micron, making the test highly sensitive, which cannot be achieved using conventional testing methods.

Ensuring Accurate and Repeatable Results

Accuracy and repeatability are essential for successful validation. Validation studies should confirm that the helium leak detection system consistently produces reliable results across multiple tests and sample sets.

Best practices for improving repeatability include:

• Performing routine calibration checks.
• Using certified leak standards.
• Maintaining controlled testing conditions.
• Conducting regular instrument verification.
• Monitoring system performance over time.

Automated helium leak testing systems also help reduce operator variability and improve testing consistency.

Evaluating Temperature and Environmental Conditions

Many biologics and advanced pharmaceutical products require cold-chain or ultra-low temperature storage. Validation programs should therefore evaluate package integrity under actual storage and transportation conditions.

PTI offers helium leak testing systems designed for low-temperature applications, including testing environments down to -140°C. These systems help manufacturers identify leaks that may develop due to material contraction or elastomer changes during cold storage.

Testing only at room temperature may not accurately represent real-world package performance.

Conclusion

Validating helium leak detection methods in CCIT is essential for ensuring accurate, repeatable, and reliable package integrity testing. By using calibrated leak standards, establishing quantitative leak rate criteria, evaluating environmental conditions, and maintaining regulatory compliance, manufacturers can strengthen product quality and sterility assurance.

As pharmaceutical packaging systems continue to evolve, helium leak detection remains one of the most sensitive and effective technologies available for modern CCIT validation applications.

Pre-filled syringes are widely used in the pharmaceutical industry because they offer accurate dosing and are easy to handle. However, their multi-part design makes it more challenging to maintain a strong sterile barrier. Even very small defects in the container can affect product sterility and stability.

For this reason, Container Closure Integrity Testing (CCIT) is essential during both development and manufacturing. Among the available methods, helium leak detection is recognized for its high sensitivity and ability to directly measure leaks, making it a reliable approach for ensuring package integrity.

Preventing Contamination in Complex Syringe Systems

Pre-filled syringes are made up of multiple components, including the barrel, plunger, stopper, and needle assembly. Each of these interfaces can become a potential leak path. Defects introduced during manufacturing, assembly, or handling may not be visible, yet they can still compromise sterility.

Helium leak detection enables direct evaluation of these systems by measuring gas escaping through any existing defects. This helps identify integrity issues early and supports corrective actions before products reach the market.

Why Helium is Ideal for Detecting Leaks

The design of pre-filled syringes involves tight tolerances, especially around the plunger seal and needle shield. These areas must maintain a secure seal while still functioning properly.

Helium is particularly effective for leak detection because of its small atomic size and inert nature. It can pass through extremely fine defects that other methods may miss, without reacting with the product or packaging materials. This makes it well suited for accurately assessing critical sealing areas.

Limitations of Traditional Methods and the Advantage of Helium Testing

Traditional leak testing methods, such as vacuum decay, have certain limitations:

• They rely on indirect measurements like pressure changes.
• They may not detect very small or sub-micron leaks.
• Sensitivity can be limited for complex packaging systems.

Helium leak detection addresses these challenges by:

• Directly measuring tracer gas flow through defects.
• Providing higher sensitivity for detecting micro-leaks.
• Delivering precise and quantitative leak rate data.
• Producing reliable and repeatable results.
• Supporting scientifically defined acceptance criteria.
• Aligning with regulatory expectations for deterministic CCIT methods.

By applying SIMS 1915+ early in development, manufacturers can prevent design flaws from progressing into scale-up, reduce costly rework, and generate strong evidence for regulatory submissions.

Maintaining Seal Integrity During Use and Storage

Pre-filled syringes are exposed to various stresses throughout their lifecycle, including filling, transportation, storage, and use. Mechanical movement, such as plunger actuation, and environmental factors like temperature changes can impact seal performance.

Helium leak detection allows testing under controlled conditions, including vacuum and temperature variations. This helps evaluate how the packaging system performs in real-world scenarios and ensures that seal integrity is maintained over time.

Preventing Microbial Entry Through Micro-Leaks

Maintaining sterility is critical for pre-filled syringes used in patient care. Even microscopic leaks can create pathways for microbial ingress, potentially compromising product safety.

Helium leak detection helps reduce this risk by identifying leaks that are too small to be detected by less sensitive methods. Its deterministic approach ensures consistent and reproducible results, strengthening quality control and supporting regulatory compliance.

Conclusion

Ensuring sterile barrier integrity in pre-filled syringes is essential for maintaining product safety and quality. Due to the complexity of these systems, advanced and sensitive testing methods are required.

Helium leak detection provides a reliable solution by offering direct and quantitative measurement of leak rates. Its ability to detect very small defects and evaluate performance under different conditions makes it a valuable tool in both development and production. As pharmaceutical packaging continues to evolve, helium leak detection remains a key technology for ensuring integrity and protecting patient health.

Evaluating vial integrity is an important part of ensuring the safety and quality of parenteral drug products. Since these medicines are often injected directly into the body, the packaging must provide a completely secure and sterile barrier throughout the product’s shelf life. Even a very small defect in a vial can allow the entry of moisture, gases, or contaminants, which may affect product stability and patient safety.

To manage this risk, pharmaceutical companies use advanced testing methods to check if the container is properly sealed. One of the most trusted methods is helium leak detection because it can find even very tiny leaks that traditional testing methods may miss. This makes it very useful for keeping medicines safe, especially sensitive products like biologics and sterile injections.

Why Helium is Considered the Standard for Microleak Detection

Helium leak testing uses helium gas as a tracer to identify leaks in sealed packaging systems. In pharmaceutical applications, it is widely used because it can detect very fine defects that other methods often miss.

Helium is extremely small in molecular size, which allows it to pass through tiny leak paths or micro-channels. At the same time, it is chemically inert, so it does not interact with the drug product or packaging materials during testing. These characteristics make helium a dependable option for evaluating package integrity without altering the sample.

Importance of Container Closure Integrity in Pharmaceuticals

Container closure integrity plays a direct role in product quality and patient safety. A strong and reliable seal ensures that the drug remains protected throughout its shelf life.

Key points include:

• Maintains a sterile barrier throughout the product lifecycle.
• Prevents entry of microorganisms, gases, and moisture.
• Preserves product quality, stability, and shelf life.
• Essential for parenteral drugs administered directly into the body.
• Supports regulatory compliance and patient safety expectations.

Cryogenic Storage Considerations

Helium leak detection is a sensitive and quantitative testing method used to evaluate sealed pharmaceutical containers.

The process involves introducing helium into or around the test sample. A mass spectrometer is then used to detect any helium that escapes through potential leak paths. Because helium atoms are so small, they can pass through defects that may not be visible through conventional testing methods.

The escaping helium is measured and expressed as a leak rate, giving a clear numerical value for container integrity. This makes the method highly reliable for detecting microleaks and assessing packaging performance.

Ensuring Safety for Biologics and Injectables

Biologics and injectable drugs are very sensitive to environmental changes. Even a small defect in the packaging can allow air, moisture, or other contaminants to enter, which may affect the quality and safety of the product. Since these medicines are directly given into the body, any loss in sterility or stability can lead to serious health risks.

Ensuring strong container closure integrity is therefore very important for these products. Advanced testing methods like helium leak detection help identify even the smallest leaks in packaging. This supports better protection of biologics and injectables, helping maintain their effectiveness and ensuring patient safety.

Applications Across Pharmaceutical Industries

Helium leak detection is widely used across different pharmaceutical packaging formats to ensure product protection and sterility.

• Pre-filled syringes: Helps ensure safe and leak-free delivery of injectable medicines.
• Vials: Maintains airtight sealing for biologics and sterile injectables.
• Cartridges: Supports integrity in delivery systems such as pens and auto-injectors.
• Bottles: Protects liquid formulations from contamination and environmental exposure.
• Foil pouches: Verifies seal integrity and prevents external contamination

Conclusion

Maintaining container integrity is essential for protecting drug quality, especially for sensitive and injectable products. As pharmaceutical formulations become more advanced, the need for accurate and reliable testing methods continues to grow.

Helium leak detection offers a highly sensitive and quantitative approach to identifying microleaks that may go unnoticed with traditional methods. By providing clear and measurable results, it supports better quality control and helps ensure that pharmaceutical products remain safe, stable, and effective throughout their lifecycle.

Presentation Summary

At the 2019 PDA Container Closure Integrity Testing Workshop in Gothenburg, Sweden, the following presentation was given as a 20 minute introduction to the use of helium leak detection for container closure integrity testing (CCIT).

Presented on behalf of Leak Detection Associates, the world’s premier manufacturer of custom-built helium leak detection solutions for pharmaceutical, biotechnology, medical device and food packaging clients, the presentation seeks to impart reviewers with an overview understanding of helium leak detection principles of operation, realistic methods for application to pharmaceutical packaging, and case study applications.

Helium gas is a small, nonreactive molecule, making it an ideal tracer for leakage testing, as employed by LDA’s SIMS 1915+ Helium Leak Detector. However, when it comes to preparing samples and subjecting them to a test, there are a range of approaches, each with respective ideal use cases. This presentation aims to illustrate some of the more common ways in which helium leak testing is applied to pharmaceutical packaging such as blisters, vials, and syringes. Reviewed approaches include the sniffer test, filling samples with helium prior to sealing, post-seal helium fill, using LDA’s proprietary vial filler and HSAM, and continuous fill using unique fixtures. Test approaches with reference to ASTM F2391 are discussed.

Important to the message of the presentation are the two case applications presented. The first discusses the application of helium leak testing to vial capping optimization, or assembly validation. In the second case application, an approach for evaluating individual ribs of a plunger is proposed. This type of approach is beneficial to those evaluating inherent integrity or defining their sterile barrier, which has implications for plunger movement during transit. This concept is becoming increasingly relevant as the expansion of prefilled syringe and cartridge-based delivery systems continues.